Biomedical Engineering Reference
In-Depth Information
Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant
acute lymphoblastic leukemia. Blood 101: 1270-1276.
925. Gati WP, Paterson AR, Larratt LM, Turner AR, Belch AR. 1997. Sensitivity of acute
leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site
content measured by flow cytometry with SAENTA-fluorescein. Blood 90: 346-353.
926. Gati WP, Paterson AR, Belch AR, Chlumecky V, Larratt LM, Mant MJ, Turner AR.
1998. Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity
to cytarabine (araC). Leuk Lymphoma 32: 45-54.
927. Hubeek I, Stam RW, Peters GJ, Broekhuizen R, Meijerink JP, van Wering ER, Gibson
BE, Creutzig U, Zwaan CM, Cloos J, et al. 2005. The human equilibrative nucleoside
transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid
leukaemia. Br J Cancer 93: 1388-1394.
928. Pennycooke M, Chaudary N, Shuralyova I, Zhang Y, Coe IR. 2001. Differential
expression of human nucleoside transporters in normal and tumor tissue. Biochem
Biophys Res Commun 280: 951-959.
929. Glue P. 1999. The clinical pharmacology of ribavirin. Semin Liver Dis 19(Suppl 1): 17-24.
930. Mangravite LM, Xiao G, Giacomini KM. 2003. Localization of human equilibrative
nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. Am J Physiol Renal
Physiol 284: F902-F910.
931. VerDonck K. 1994. Purine metabolism in the heart. Strategies for protection against
myocardial ischaemia. Pharm World Sci 16: 69-76.
932. Dennis DM, Raatikainen P, Martens JR, Belardinelli L. 1996. Modulation of atrioven-
tricular nodal function by metabolic and allosteric regulators of endogenous adenosine
in guinea-pig heart. Circulation 94: 2551-2559.
933. Mubagwa K, Flameng W. 2001. Adenosine, adenosine receptors and myocardial
protection: an updated overview. Cardiovasc Res 52: 25-39.
934. Martin BJ, Lasley RD, Mentzer RM Jr. 1997. Infarct size reduction with the nucleoside
transport inhibitor R-75231 in swine. Am J Physiol 272: H1857-H1865.
935. Parkinson FE, Rudolphi KA, Fredholm BB. 1994. Propentofylline: a nucleoside
transport inhibitor with neuroprotective effects in cerebral ischemia. Gen Pharmacol 25:
1053-1058.
936. Parkinson FE, Paterson AR, Young JD, Cass CE. 1993. Inhibitory effects of propento-
fylline on [3H]adenosine influx. A study of three nucleoside transport systems. Biochem
Pharmacol 46: 891-896.
937. Andine P, Rudolphi KA, Fredholm BB, Hagberg H. 1990. Effect of propentofylline (HWA
285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus
during transient ischaemia. Br J Pharmacol 100: 814-818.
938. Dux E, Fastbom J, Ungerstedt U, Rudolphi K, Fredholm BB. 1990. Protective effect
of adenosine and a novel xanthine derivative propentofylline on the cell damage after
bilateral carotid occlusion in the gerbil hippocampus. Brain Res 516: 248-256.
939. Parkinson FE, Zhang YW, Shepel PN, Greenway SC, Peeling J, Geiger JD. 2000. Effects
of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor
activity in rat forebrain ischemia. J Neurochem 75: 795-802.
940. Zhang YW, Shepel PN, Peeling J, Geiger JD, Parkinson FE. 2002. Effects of ni-
trobenzylthioinosine on adenosine levels and neuronal injury in rat forebrain ischemia.
Neurosci Res Commun 30: 80-89.
Search WWH ::
Custom Search